Asia Pacific Platelet Rich Plasma (prp) Market Size & Outlook

The platelet rich plasma (prp) market in Asia Pacific is expected to reach a projected revenue of US$ 422.6 million by 2033. A compound annual growth rate of 15.2% is expected of Asia Pacific platelet rich plasma (prp) market from 2026 to 2033.
Revenue, 2025 (US$M)
$137.0
Forecast, 2033 (US$M)
$422.6
CAGR, 2026 - 2033
15.2%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific platelet rich plasma (prp) market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific platelet rich plasma (prp) market highlights

  • The Asia Pacific platelet rich plasma (prp) market generated a revenue of USD 137.0 million in 2025.
  • The market is expected to grow at a CAGR of 15.2% from 2026 to 2033.
  • In terms of segment, pure prp was the largest revenue generating type in 2025.
  • Others Type is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, Japan is expected to register the highest CAGR from 2026 to 2033.


Asia Pacific data book summary

Market revenue in 2025USD 137.0 million
Market revenue in 2033USD 422.6 million
Growth rate15.2% (CAGR from 2026 to 2033)
Largest segmentPure prp
Fastest growing segmentOthers Type
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPure PRP, Leukocyte Rich PRP, Others Type
Key market players worldwideJohnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 21.1% of the global platelet rich plasma (prp) market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 422.6 million by 2033.

Pure prp was the largest segment with a revenue share of 56.42% in 2025. Horizon Databook has segmented the Asia Pacific platelet rich plasma (prp) market based on pure prp, leukocyte rich prp, others type covering the revenue growth of each sub-segment from 2021 to 2033.


The Asia Pacific market is expected to witness the fastest growth in the near future. The rising number of cosmetic surgeries to improve facial features in Korea, India, and Thailand is anticipated to boost the regional market. In addition, growing medical tourism industry is expected to boost the adoption of PRP treatments.

In some cases, PRP therapy can prevent the need for surgery, which is aiding in market growth. This includes treating damaged tissues to prevent damage progression in orthopedics, joint replacement, and spinal fusion. The presence of a strong research base for PRP therapies is expected to boost their adoption in the region.

China, Japan, and India are significantly contributing to the region's market growth. Active involvement of academic and research institutes, such as the University of Tsukuba and Guangzhou University of Chinese Medicine, for evaluating the application of PRP therapies is expected to fuel the market.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Platelet Rich Plasma (PRP) Market Companies

Name Profile # Employees HQ Website
Celling Biosciences View profile - -
APEX Biologix View profile 11-50 Murray, Utah, United States, North America https://apexbiologix.com
Juventix Regenerative Medical View profile 11-50 Tampa, Florida, United States, North America https://juventix.com/
Dr. PRP USA View profile 11-50 Stafford, Texas, United States, North America https://www.drprpusa.com
EmCyte Corporation View profile 11-50 Fort Myers, Florida, United States, North America https://emcyte.com/
Arthrex View profile 5001-10000 Naples, Florida, United States, North America https://www.arthrex.com/
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Asia Pacific platelet rich plasma (prp) market size, by country, 2021-2033 (US$M)

Asia Pacific Platelet Rich Plasma (PRP) Market Outlook Share, 2025 & 2033 (US$M)

Asia Pacific platelet rich plasma (prp) market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online